当前位置：首页 SCI期刊 SCIE期刊医学中科院1区 JCRQ1 期刊介绍(非官网)

Advanced Drug Delivery ReviewsSCIE

国际简称：ADV DRUG DELIVER REV 参考译名：先进的药物输送审查

中科院分区
1区
CiteScore分区
Q1
JCR分区
Q1

基本信息：: ISSN：0169-409X; E-ISSN：1872-8294; 是否OA：未开放; 是否预警：否; TOP期刊：是

出版信息：: 出版地区：NETHERLANDS; 出版商：Elsevier; 出版语言：English; 出版周期：Monthly; 出版年份：1987; 研究方向：药学-医学

评价信息：: 影响因子：15.2; H-index：278; CiteScore指数：28.1; SJR指数：3.411; SNIP指数：2.46

发文数据：: Gold OA文章占比：31.54%; 研究类文章占比：0.57%; 年发文量：174; 自引率：0.0496...; 开源占比：0.1785; 出版撤稿占比：0; 出版国人文章占比：0.07; OA被引用占比：0.0807...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Advanced Drug Delivery Reviews期刊介绍

The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.

In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.

Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.

期刊简介Advanced Drug Delivery Reviews期刊介绍

《Advanced Drug Delivery Reviews》自1987出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：一般,3-8周约15.1周
国际TOP期刊
医学
PHARMACOLOGY & PHARMACY
SCIE
中科院1区
非预警

Cite Score数据（2024年最新版）Advanced Drug Delivery Reviews Cite Score数据

CiteScore：28.1
SJR：3.411
SNIP：2.46

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmaceutical Science	Q1	1 / 183	99%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Advanced Drug Delivery Reviews 中科院分区

中科院 2023年12月升级版 综述期刊：是 Top期刊：是

大类学科	分区	小类学科	分区
医学	1区	PHARMACOLOGY & PHARMACY 药学	1区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Advanced Drug Delivery Reviews JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	4 / 354	99%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	7 / 354	98.16%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
USA197
CHINA MAINLAND47
Australia43
England38
GERMANY (FED REP GER)38
France30
Netherlands27
Japan26
Canada17
Denmark15

本刊中国学者近年发表论文

1、Advances in image-guided drug delivery for antibacterial therapy
Author: Huang, Haiyan; Ali, Arbab; Liu, Yi; Xie, Hui; Ullah, Sana; Roy, Shubham; Song, Zhiyong; Guo, Bing; Xu, Jian

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 192, Issue , pp. -. DOI: 10.1016/j.addr.2022.114634
2、Design strategies and applications of smart optical probes in the second near-infrared window
Author: Chang, Baisong; Chen, Jie; Bao, Jiasheng; Dong, Kangfeng; Chen, Si; Cheng, Zhen

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 192, Issue , pp. -. DOI: 10.1016/j.addr.2022.114637
3、Radiation-assisted strategies provide new perspectives to improve the nanoparticle delivery to tumor
Author: Zhang, Dongxiao; He, Jian; Zhou, Min

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 193, Issue , pp. -. DOI: 10.1016/j.addr.2022.114642
4、Nanomaterials and nanomaterials-based drug delivery to promote cutaneous wound healing
Author: Liu, Tengfei; Lu, Yifei; Zhan, Rixing; Qian, Wei; Luo, Gaoxing

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 193, Issue , pp. -. DOI: 10.1016/j.addr.2022.114670
5、Role of wound microbiome, strategies of microbiota delivery system and clinical management
Author: Tang, Qinghan; Xue, Nannan; Ding, Xiaofeng; Tsai, Kevin H. -Y.; Hew, Jonathan J.; Jiang, Ruihan; Huang, Rizhong; Cheng, Xuxi; Ding, Xiaotong; Cheng, Yuen Yee; Chen, Jun; Wang, Yiwei

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 192, Issue , pp. -. DOI: 10.1016/j.addr.2022.114671
6、Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy
Author: Sun, Yinping; Sha, Yongjie; Cui, Guanhong; Meng, Fenghua; Zhong, Zhiyuan

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 192, Issue , pp. -. DOI: 10.1016/j.addr.2022.114624
7、Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors
Author: Sun, Wenjing; Chu, Chengchao; Li, Shi; Ma, Xiaoqian; Liu, Peifei; Chen, Shileng; Chen, Hongmin

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 192, Issue , pp. -. DOI: 10.1016/j.addr.2022.114643
8、Protein encapsulation of nanocatalysts: A feasible approach to facilitate catalytic theranostics
Author: Jin, Duo; Liu, Manman; Zhang, Meng; Yu, Wenxin; Yu, Jiaji; Shen, Aizong; Cheng, Junjie; Liu, Yangzhong

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 192, Issue , pp. -. DOI: 10.1016/j.addr.2022.114648